(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -340.30%-346.26K | 411.06%282.02K | 163.01%225.38K | 95.54%-52.83K | 214.30%328.3K | 34.02%-78.64K | 114.33%55.18K | 8.95%-357.69K | -1,361.03%-1.18M | -44.22%-287.22K |
Net income from continuing operations | 61.89%110.36K | -57.10%13.06K | 67.31%-125.75K | 62.31%-497.77K | 69.80%-213.11K | 130.28%68.17K | 152.92%30.44K | -15.67%-384.65K | -116.89%-1.32M | -95.66%-705.6K |
Operating gains losses | -108.13%-1.11K | ---1.14K | ---1.16K | --11.37K | ---2.31K | --13.69K | ---- | ---- | ---- | ---- |
Depreciation and amortization | -20.36%5.52K | -21.11%5.39K | -21.58%5.33K | -66.76%27.07K | -40.45%6.51K | -70.77%6.93K | -70.83%6.84K | -70.90%6.8K | -15.67%81.44K | -55.32%10.93K |
Asset impairment expenditure | --0 | --5.92K | --4.63K | -76.42%3.23K | --3.23K | --0 | --0 | --0 | -36.64%13.7K | ---- |
Remuneration paid in stock | -25.74%13.18K | -25.74%13.18K | -25.74%13.18K | -60.89%69.26K | -66.04%16.01K | -60.34%17.75K | -58.34%17.75K | -58.34%17.75K | 54.95%177.12K | -30.18%47.16K |
Other non cashItems | 85.71%156 | ---- | ---56.4K | -99.07%84 | --0 | 4,300.00%84 | ---- | ---- | -71.46%9K | -70.72%8.5K |
Change In working capital | -156.08%-474.21K | 158,351.61%245.6K | 13,534.84%329.15K | 331.20%334K | 53.20%517.96K | -594.17%-185.18K | 100.04%155 | 101.91%2.41K | -132.69%-144.46K | 1,643.38%338.09K |
-Change in receivables | -206.21%-648.86K | -157.77%-130.02K | 129.22%50K | 133.48%38.09K | -9.80%300.91K | -56.49%-211.9K | 166.84%225.06K | -791.02%-171.14K | -7,283.84%-113.79K | 144.30%333.61K |
-Change in prepaid assets | 176.48%18.46K | -158.56%-4.99K | -298.84%-22.65K | 49.67%-15.96K | 600.52%5.35K | -2,017.63%-24.14K | 156.03%8.52K | 69.34%-5.68K | -3,088.78%-31.71K | -95.36%763 |
-Change in payables and accrued expense | 100.74%469 | -95.78%3.84K | -7,172.84%-122.11K | 466.98%92.26K | 657.88%67.82K | -484.31%-63.55K | 41.75%90.93K | 98.54%-1.68K | -266.37%-25.14K | -29.15%8.95K |
-Change in other working capital | 36.10%155.71K | 216.16%376.77K | 134.32%423.91K | 739.06%219.61K | 2,853.25%143.89K | -26.22%114.42K | -206.18%-324.36K | 1,119.45%180.91K | -93.87%26.17K | 96.43%-5.23K |
Interest paid (cash flow from operating activities) | -85.71%-156 | ---- | ---- | 83.10%-84 | --0 | ---84 | ---- | ---- | 83.83%-497 | --0 |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -340.30%-346.26K | 411.06%282.02K | 147.24%168.98K | 95.54%-52.83K | 214.30%328.3K | 34.02%-78.64K | 114.32%55.18K | 8.95%-357.69K | -1,361.03%-1.18M | -44.23%-287.22K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -13.55%-2.95K | 130.00%450 | 116.76%436 | 45.53%-6.3K | -95.80%402 | 60.60%-2.6K | 58.84%-1.5K | 76.14%-2.6K | 91.76%-11.57K | 109.40%9.57K |
Net PPE purchase and sale | -100.19%-5.2K | -20.00%-1.8K | 30.26%-1.81K | 77.67%-7.05K | 96.66%-348 | 60.60%-2.6K | 58.84%-1.5K | 76.14%-2.6K | 30.52%-31.57K | -52.32%-10.43K |
Net other investing changes | --2.25K | --2.25K | --2.25K | -96.25%750 | ---- | ---- | ---- | ---- | 121.05%20K | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -13.55%-2.95K | 130.00%450 | 116.76%436 | 45.53%-6.3K | -95.80%402 | 60.60%-2.6K | 58.84%-1.5K | 76.14%-2.6K | 91.76%-11.57K | 109.40%9.57K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 0 | 0 | -99.92%600 | 0 | 0 | 0 | 113.85%600 | -0.21%710.79K | -133.14%-18.71K |
Net issuance payments of debt | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 30.13%-85.32K | -117.75%-1.86K |
Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --784.6K | --53.68K |
Proceeds from stock option exercised by employees | --0 | --0 | --0 | -97.00%600 | --0 | --0 | --0 | -97.00%600 | -97.68%20K | -155.05%-53.68K |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 70.13%-8.5K | 67.29%-16.85K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | --0 | --0 | -99.92%600 | --0 | --0 | --0 | 113.85%600 | -0.21%710.79K | -133.14%-18.71K |
Net cash flow | ||||||||||
Beginning cash position | 175.68%1.1M | 136.63%814.97K | -8.31%645.55K | -40.80%704.08K | -68.33%316.85K | -65.42%398.09K | -55.92%344.41K | -40.80%704.08K | 127.17%1.19M | -30.23%1M |
Current changes in cash | -329.85%-349.21K | 426.18%282.47K | 147.10%169.42K | 87.94%-58.53K | 210.91%328.7K | 46.16%-81.24K | -85.49%53.68K | 11.86%-359.69K | -172.89%-485.27K | -21.19%-296.36K |
End cash Position | 136.14%748.22K | 175.68%1.1M | 136.64%814.96K | -8.31%645.55K | -8.31%645.55K | -68.33%316.85K | -65.42%398.09K | -55.92%344.39K | -40.80%704.08K | -40.80%704.08K |
Free cash from | -332.62%-351.46K | 421.98%280.22K | 146.40%167.17K | 95.08%-59.88K | 210.18%327.95K | 35.41%-81.24K | 113.80%53.68K | 10.76%-360.29K | -2,607.38%-1.22M | -44.49%-297.65K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data